cephalosporin c has been researched along with amoxicillin-potassium clavulanate combination in 192 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (7.29) | 18.7374 |
1990's | 80 (41.67) | 18.2507 |
2000's | 65 (33.85) | 29.6817 |
2010's | 25 (13.02) | 24.3611 |
2020's | 8 (4.17) | 2.80 |
Authors | Studies |
---|---|
De Abate, CA; Dennington, ML; Perrotta, RJ; Ziering, RM | 1 |
Blandino, G; Caccamo, F; Di Marco, R; Nicoletti, A; Nicoletti, G; Speciale, A | 1 |
Verbist, L; Verhaegen, J | 1 |
Gwaltney, J; Huck, W; Nielsen, RW; Scheld, WM; Sydnor, TA; Therasse, DG | 1 |
Foshee, WS | 1 |
Arguedas, AG; Stutman, HR | 1 |
Pelletier, LL | 1 |
Zeckel, ML | 1 |
Hyslop, DL | 1 |
Nielsen, RW | 1 |
Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
Andrews, JM; Baldwin, DR; Cooper, MA; Thornber, D; Wise, R | 1 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
Gan, VN; Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
Arguedas, AG; Blumer, JL; Hains, CS; Stutman, HR; Zaleska, M | 1 |
Pichler, HE | 1 |
Chin, NX; Gu, JW; Neu, HC | 1 |
Dolna, I; Gościniak, G; Ruczkowska, J | 1 |
Askew, C; Kingston, RD; Lawson, W; Lomax, J | 1 |
Luckhaupt, H | 1 |
Crokaert, F; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
Jorgensen, JH; Maher, LA; Ramirez, PE; Redding, JS | 1 |
Citron, DM; Goldstein, EJ | 1 |
Chin, NX; Neu, HC | 1 |
Fitzgerald, MX; Flavell-Matts, SG; Howell, F; McKenzie, A; McNicholas, W; O'Donovan, C; O'Neill, S; Rudd, R; Whittaker, J | 1 |
Ansink-Schipper, MC; Michel, MF; Schift, R; Stolz, E; van Joost, T; van Ulsen, J; Woudstra, RK | 1 |
Brown, GW; Cox, DM; Hebblethwaite, EM; Plested, SJ; Williams, KJ | 1 |
Brown, GW; Cox, DM; Hebblethwaite, EM | 1 |
Chau, PY; Leung, YK; Ng, WS; Wong, PC | 1 |
Flenley, DC | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Mccarty, JM; Mclinn, SE; Perrotta, R; Pichichero, ME; Reidenberg, BE | 1 |
Cellesi, C; Mencarelli, M; Rossolini, A; Sansoni, A; Zanchi, A | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Cohen, R | 1 |
Ball, P | 1 |
Kafetzis, DA | 1 |
Nolen, T | 1 |
Berche, P; Bingen, E; Boucot, I; Gehanno, P; Gres, JJ; Lambert-Zechovsky, N; Rollin, C | 1 |
Garcia Iglesias, MC; Perea, EJ | 1 |
Andrews, JM; Lees, AS; Wise, R | 1 |
Brown, BA; Nash, DR; Steele, LC; Steingrube, VA; Wallace, RJ; Young, G; Zhang, Y | 1 |
Barry, AL; Fuchs, PC; Pfaller, MA | 1 |
Bégué, P; Boulesteix, J; Dabernat, H; de La Rocque, F; Dubreuil, C; Geslin, P; Mégraud, F; Trinh, A | 1 |
Chardon, H; Farzaneh, S; Jarlier, V; Labia, R; Nicolas, MH; Paul, G; Poyart, C; Sirot, D; Sirot, J | 1 |
Collins, JJ; Drehobl, M; Giguere, G; Henry, D; Puopolo, A; Rhudy, J; Ruoff, GE; Schoenberger, J | 1 |
Chanal, C; Dabernat, H; Huc, C; Labia, R; Lemozy, J; Sirot, D; Sirot, J | 1 |
Behler, PG; Böge, K; Böhning, W; Gams, W; Gartner-Toth, M; Wettengel, R | 1 |
Nieto, E; Parra, A; Ponte, C; Soriano, F | 1 |
Gürses, N; Islek, I; Kalayci, AG; Uysal, S | 1 |
Ozsoylu, S | 1 |
Gooch, WM; Philips, A; Rhoades, R; Rosenberg, R; Schaten, R; Starobin, S | 1 |
Feely, J; Hemeryck, L; McGettigan, P | 1 |
Collins, JJ; Feris, J; Giguere, G; Hidalgo, H; Higuera, F | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Gwaltney, JM; Keyserling, C; Leigh, A; Rivas, P; Savolainen, S; Scheld, WM; Schenk, P; Sydnor, A; Tack, KJ | 1 |
Barendregt, D; Dellemijn-Kippuw, N; Stijne, A; van der Velden, U; van Winkelhoff, AJ; Winkel, EG | 1 |
Lim, TK | 1 |
Booy, R; Kroll, JS | 1 |
Amir, J; Cohen, A; Eilam, N; Fuchs, C; Horev, Z; Jaber, L; Laks, Y; Robinson, J; Rosenbaum, I; Varsano, I; Volovitz, B | 1 |
Konstantinova, TD; Lenkova, NI; Minaev, VI; Nonikov, VE; Ritchik, LA | 1 |
Palcevski, G; Vitezić, D; Vlahović Palcevski, V | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
Bégué, P; Boulesteix, J; Dabernat, H; de La Roque, F; Dubreuil, C; Geslin, P; Megraud, F; Scheimberg, A; Trinh, A | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Joseph, EM; Sperling, NM | 1 |
Brook, I; Gober, AE | 2 |
Dohnalová, J; Fucíková, Z; Jedlicková, A; Krejcí, V; Mára, M; Zivný, J | 1 |
Anderson, AN; Ebrahim, O; Wessels, F | 1 |
Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
Berenholz, LP; Kessler, A; Segal, S | 1 |
Ispahani, P; Punt, J; Vloebeghs, M; Watson, AR; Weston, VC | 1 |
Wittmann, DH | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Baños, V; Canteras, M; Gómez Vargas, J; Gómez, J; Muñoz, L; Ruiz Gómez, J; Sánchez, ME; Simarro, E; Soto, MC; Valdés, M | 1 |
Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
Deschilder, I; Liekens, K; Lontie, M | 1 |
Léophonte, P | 1 |
Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
Dillman, CA; Kierszenbaum, JS; Macias, MP; Ramos, BD; Soliman, AE; Subba Rao, SD | 1 |
Hamilton-Miller, JM; Shah, S | 1 |
Boucherat, M; Cohen, R; Derriennic, M; Geslin, P; Goehrs, JM; Grunberg, J; Navel, M; Pichon, F | 1 |
Green, L; Miller, G; Stein, M | 1 |
Bunnik, MC; de Klerk, GJ; Dofferhof, AS; Geraedts, WH; Hensing, CA; Hoepelman, AI; Jaspers, CA; Lobatto, S; Melis, JH; Van Den Berg, J; van Steijn, JH; van Veldhuizen, WC | 1 |
Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F | 2 |
Allen, J; Burroughs, S; Cobb, MM; Henry, DC; Holley, HP; Settipane, GA; Sydnor, A | 1 |
Dagan, R; Gehanno, P; Leblanc, F; Leibovitz, E; Machac, J; Marr, C; Pessey, JJ; Pimentel, JM; Thoroddsen, E | 1 |
Kostense, PJ; Smeele, LE; Tuinzing, DB; Zijderveld, SA | 1 |
McCracken, GH | 1 |
Aguilar, L; Balcabao, IP; Giménez, MJ; Gómez-Lus, ML; Prieto, J | 1 |
Allen, BS; Bandak, SI; Bolzon, LD; Henle, SK; Johns, D; Turnak, MR | 1 |
Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M | 1 |
Schenk, P; Steurer, M | 1 |
Dagan, R; Leibovitz, E | 1 |
Abad, L; Martinez-Alfaro, E; Solera, J; Solís-Garcia del Pozo, J | 1 |
Lumbiganon, P; Panamonta, O | 1 |
Butkevich, OM; Vinogradova, TL | 1 |
Ochoa, C; Pérez Méndez, C; Solís, G | 1 |
Bagilet, D; Diab, M; Javkin, E; Kalbermatter, V | 1 |
Block, SL; Hedrick, JA; Keyserling, CH; McCarty, JM; Nemeth, MA; Tack, KJ | 1 |
Adler, M; Keyserling, C; McDonald, PJ; Tack, K; Trostmann, U | 1 |
Gooch, WM; Oddo, LP; Powers, JL | 1 |
Al-Ammar, AY | 1 |
Hedrick, JA; Pierce, P; Schwartz, RH; Sher, LD | 1 |
Carratalà, J; Dorca, J; Gudiol, F; Liñares, J; Manresa, F; Pallares, R; Rosón, B; Tubau, F | 1 |
de Dios del Valle, R; Franco Vidal, A; Hernández Sánchez, A; Palancar de la Torre, JL | 1 |
Edlund, C; Lund, B; Lundgren, Y; Nord, CE; Rynnel-Dagöö, B; Sterner, J | 1 |
Orrett, FA; Shurland, SM | 1 |
Gul, YA; Jabar, FM; Lian, LH; Moissinac, K | 1 |
Appelbaum, PC; Bozdogan, B; Clark, C; Dewasse, B; Jacobs, MR; Peric, M | 1 |
Blahová, J; Jezek, P; Králiková, K; Krćméry, V; Vaculíková, A | 1 |
Craig, WA; Cyganowski, M; Fogarty, CM; Hom, RC; Palo, WA | 1 |
Danziger, LH; Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
Bernatoniene, G; Kaltenis, P; Murauskaite, G | 1 |
Baquero, F; Baquero, MR; Galán, JC; Morosini, MI; Reig, M | 1 |
Caronzolo, D; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
Encheva, D; Hernández, MA; Horen, B; Krajnakova, H; Kriska, M; Kumari, M; Lapeyre-Mestre, M; Martínez-Mir, I; Momcheva, H; Palop, V; Peiré, MA; Ratchina, S; Sanz, E; Stratchounsky, L | 1 |
Kaye, KM; Martin, SI | 1 |
Block, SL; Bukofzer, S; Busman, TA; Paris, MM | 1 |
Kunselman, AR; Lin, HM; Lyles, RH; Williamson, JM | 1 |
Ah-See, K | 3 |
Bukofzer, S; Cifaldi, MA; Devcich, KJ; Paris, MM | 1 |
Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
Cooper, CE; Griffin, KE; Slocombe, B | 1 |
Chiu, YL; Holas, C; Kapral, D; Notario, G | 1 |
Kim, HJ; Lee, K; Song, JW; Yoo, JB; Yoon, JH | 1 |
Appelbaum, PC; Bogdanovich, T; Clark, C; Ednie, L; Lin, G; Shapiro, S; Smith, K | 1 |
Akinlade, BK; Block, SL; Busman, TA; Halpern, MT; Mackinnon, GE; Nilius, AM; Notario, GF; Schmier, JK | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L | 1 |
Patel, SM; Saravolatz, LD | 1 |
Carlet, J | 1 |
Ferraro, SM; Giacomelli, L; Marchese-Ragona, R; Marioni, G; Ottaviano, G; Rinaldi, R; Staffieri, A; Staffieri, C | 1 |
Fritsche, TR; Jacobs, MR; Sader, HS | 1 |
Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
Beard, K; Burton, P; Douglas, E; Dundas, S; Gourlay, Y; MacKenzie, AR; McLaughlin, C; Nathwani, D; Seaton, RA; Ziglam, H | 1 |
Hotomi, M; Yamanaka, N | 1 |
Billal, DS; Hotomi, M; Yamanaka, N | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Eiros Bouza, JM; Ochoa Sangrador, C | 1 |
Andreu, L; Cañizares, R; Cuadrado, JM; de la Tabla, VO; Jover, F; Martin, C; Martínez, S; Merino, J; Roig, P | 1 |
Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J | 1 |
Kitcharoensakkul, M; Poachanukoon, O | 1 |
Alifano, M; Casetta, A; Coignard, S; Dermine, H; Magdeleinat, P; Meunier, A; Rabbat, A; Regnard, JF; Roche, N; Salvi, M; Schussler, O; Strano, S | 1 |
Stiefelhagen, P | 1 |
Bergman, M; Hakanen, AJ; Huovinen, P; Nyberg, ST; Paakkari, P | 1 |
Bianchetti, MG; Borsari, AG; Brazzola, P; Bucher, B; Dolina, M; Simonetti, GD | 1 |
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Aguilar, L; Coronel, P; Gimenez, MJ; Gimeno, M; Granizo, JJ; Prieto, J | 1 |
Coco, AS; Gambler, AS; Horst, MA | 1 |
Citron, DM; Goldstein, EJ; Merriam, CV; Tyrrell, KL | 1 |
Chan, KS; Chuang, YC; Kuo, CY; Tsai, CL; Yu, WL | 1 |
Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
Huang, TD; Lebitasy, M; Rodriguez-Villalobos, H; Simon, A | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; López, AM; Prieto, J; Sevillano, D; Torrico, M | 1 |
Beckius, ML; Glasser, JS; Markelz, AE; Mende, K; Murray, CK; Zera, WC | 1 |
Calas, P; Jabri, M; Rochd, T; Roques, C | 1 |
Cercenado, E; de Toro, M; García-Campello, M; Rojo-Bezares, B; Sáenz, Y; Torres, C; Undabeitia, E | 1 |
Constable, PD; Litster, AL; Wu, CC | 1 |
Alós, JI; Martín-Pozo, A | 1 |
Almudevar, A; Block, SL; Casey, JR; Hedrick, J; Pichichero, ME | 1 |
Beraud, G; Cadranel, J; Godet, C | 1 |
Pichichero, ME | 1 |
Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC | 1 |
Correa Signoretti, FG; Gomes, BP; Grecca, FS; Jacinto, RC; Montagner, F; Scheffer de Mattos, V | 1 |
Singh, HL; Singh, RM | 1 |
Du, X; Fu, Y; Ji, S; Jiang, Y; Lv, F; Mu, X; Wei, Z; Yu, Y | 1 |
Kang, JN; Kim, DH; Kim, H; Park, IH; Park, SH; Seo, JK; Seol, JE | 1 |
Atkinson, A; Kronenberg, A; Lo Priore, EF; Marschall, J; Sommerstein, R | 1 |
Barkman, D; Bell, L; Bryan, M; Conaboy, K; Fiks, AG; Gerber, JS; Localio, AR; Odeniyi, F; Ross, RK; Szymczak, JE; Wasserman, R; Zaoutis, TE | 1 |
Batard, E; Caillon, J; Chapelet, G; Javaudin, F; Marquet, A; Montassier, E; Vibet, MA | 1 |
Batard, E; Caruana, E; Chapelet, G; Goffinet, N; Javaudin, F; Kervagoret, E; Le Bastard, Q; Montassier, E | 1 |
Bouchand, F; Davido, B; Dinh, A | 1 |
Batard, E; Javaudin, F; Montassier, E | 1 |
Ergönül, Ö; Kebapcı, A; Okyay, R; Taymaz, T | 1 |
Hon, KL; Leung, AAM; Leung, AKC; Wong, AHC | 1 |
Attanasio, V; Bernardo, M; Capoluongo, N; Carozza, A; Di Luca, M; Pallotto, C; Palmiero, G; Severino, S; Tascini, C | 1 |
Cayo da Silva, R; Esimone, CO; Gales, AC; Iroha, IR; Moses, IB; Ribeiro, ÁCDS; Rubin, JE; Santos, FF; Sniatynsky, MK | 1 |
Croton, C; Gibson, JS; Haworth, M; Kalnins, NJ; Purcell, SL; Rajapaksha, B; Stewart, AJ | 1 |
Chinchilla, GC; Izquierdo, EO; Lana, PV; Molina, AG; Rosado, MR; Velasco, AL; Vidal, LS | 1 |
Akazawa, N; Ishibana, Y; Itoh, N; Kawabata, T; Kawamura, D; Kodama, EN; Murakami, H; Ohmagari, N | 1 |
Aldemir Kocabaş, B; Arısoy, ES; Aykaç, K; Çağlar, İ; Çay, Ü; Çelebi, S; Çelik, M; Çiftçi, E; Devrim, İ; Dinleyici, EÇ; Diri, T; Erat, T; Gayretli Aydın, ZG; Günay, F; Gundogdu Aktürk, H; Güven, Ş; Kaba, Ö; Kara, A; Kara, M; Kara, SS; Karaaslan, A; Karadag Oncel, E; Karakaşlılar, S; Kaya, C; Ozdemir, H; Özen, M; Özkaya Parlakay, A; Salı, E; Şen Bayturan, S; Somer, A; Sütçü, M; Tanır Basaranoğlu, S; Tanır, G; Tekin Yılmaz, A; Tezer, H; Tural Kara, T; Yaşar Durmuş, S; Yazar, AS; Yeşil, E; Yılmaz Çiftdoğan, D | 1 |
Chen, WC; Hung, JN; Lin, LL; Shiu, SI; Su, YH; Tseng, JJ | 1 |
Avison, MB; Barrows, MG; Horspool, T; Saunders, R; Sealey, JE | 1 |
31 review(s) available for cephalosporin c and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Oral cephalosporins.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Structure-Activity Relationship | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cephalosporins; Chronic Disease; Clavulanic Acids; Diarrhea; Drug Therapy, Combination; Europe; Female; Headache; Humans; Incidence; Male; Middle Aged; Treatment Outcome; United States | 1992 |
Efficacy and safety of loracarbef in the treatment of pneumonia.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Nausea; Pneumonia; Randomized Controlled Trials as Topic; Vomiting | 1992 |
Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Clavulanic Acids; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Finland; Humans; Iceland; Male; Maxillary Sinusitis; Middle Aged; Single-Blind Method; Sweden; Treatment Outcome; United States | 1992 |
[Progress in oral antibiotic therapy in practice].
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Infections; Macrolides | 1991 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
Clinical experience with cefpodoxime proxetil in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Prodrugs; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 1995 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
Is Haemophilus influenzae finished?
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Capsules; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Humans; Meningitis; Polysaccharides, Bacterial; Serotyping; Vaccines, Conjugate; Virulence | 1997 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Hospital Costs; Humans; Infant; Length of Stay; Odds Ratio; Pneumonia, Bacterial; Retrospective Studies; South Africa; Treatment Outcome | 1998 |
Antibiotic treatment for acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Drug Resistance, Microbial; Humans; Macrolides; Otitis Media; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Vertebral osteomyelitis caused by Streptococcus agalactiae.
Topics: Abscess; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Arthroplasty, Replacement, Hip; Cefazolin; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Hemoglobins; Humans; Leukocyte Count; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; MEDLINE; Middle Aged; Osteomyelitis; Penicillins; Radiography; Spondylitis; Streptococcal Infections; Streptococcus agalactiae | 2000 |
[Use of levofloxacine in primary care for outbreaks in COPD].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefuroxime; Cephalosporins; Evidence-Based Medicine; Humans; Ofloxacin; Randomized Controlled Trials as Topic | 2001 |
Beta-lactam antibiotics: newer formulations and newer agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Humans; Lactams; United States | 2004 |
Acute sinusitis.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Humans; Macrolides; Sinusitis | 2003 |
Sinusitis (acute).
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Humans; Sinusitis | 2004 |
Sinusitis (acute).
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Humans; Macrolides; Sinusitis | 2005 |
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Single-Blind Method; Smell; Suspensions; Taste | 2005 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulitis; Cephalosporins; Ciprofloxacin; Diverticulitis; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Meningitis, Bacterial; Neutropenia; Osteomyelitis; Pneumonia; Staphylococcus aureus; Viridans Streptococci | 2006 |
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
[Current status of PRSP and BLNAR].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Haemophilus influenzae; Humans; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
[Etiological profile of urinary tract infections and antimicrobial susceptibility of urinary pathogens].
Topics: Adult; Age Factors; Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Consensus Development Conferences as Topic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Evidence-Based Medicine; Fosfomycin; Hospitalization; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Penicillins; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Superinfection; Vaginitis | 2009 |
Otitis media.
Topics: Age Factors; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Child, Preschool; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Otoscopy; Streptococcus pneumoniae; Time Factors; Tympanic Membrane | 2013 |
Urinary Tract Infection in Pediatrics: Study of Uropathogens and Their Resistance in a Madrid Hospital.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Pediatrics; Retrospective Studies; Urinary Tract Infections | 2022 |
Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Chorioamnionitis; Clindamycin; Erythromycin; Female; Gentamicins; Humans; Infant, Newborn; Macrolides; Network Meta-Analysis; Pregnancy; Premature Birth | 2023 |
60 trial(s) available for cephalosporin c and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Single-Blind Method; Sinusitis | 1992 |
Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Decision Trees; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Severity of Illness Index | 1992 |
Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cephalosporins; Clavulanic Acids; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media with Effusion; Streptococcus pneumoniae | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cephalosporins; Chronic Disease; Clavulanic Acids; Diarrhea; Drug Therapy, Combination; Europe; Female; Headache; Humans; Incidence; Male; Middle Aged; Treatment Outcome; United States | 1992 |
Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Clavulanic Acids; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Finland; Humans; Iceland; Male; Maxillary Sinusitis; Middle Aged; Single-Blind Method; Sweden; Treatment Outcome; United States | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Random Allocation; Recurrence | 1991 |
Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media with Effusion; Recurrence; Streptococcus pneumoniae | 1991 |
Effectiveness of two therapeutic antibiotic regimens in the treatment of serious post-operative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic | 1989 |
Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Clinical Trials as Topic; Humans; Random Allocation; Respiratory Tract Infections | 1987 |
Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).
Topics: Administration, Oral; Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Gonorrhea; Humans; Male; Middle Aged; Probenecid; Random Allocation | 1986 |
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Respiratory Tract Infections | 1987 |
Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ceftibuten; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media with Effusion; Patient Compliance; Treatment Outcome | 1995 |
Clinical experience with cefpodoxime proxetil in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Prodrugs; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 1995 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae | 1994 |
Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Nasopharynx; Otitis Media | 1995 |
Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Clavulanic Acids; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1995 |
Amoxicillin/clavulanic acid vs cefetamet pivoxil in the treatment of acute exacerbation of chronic bronchitis (AECB) in adults.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Ceftizoxime; Cephalosporins; Chronic Disease; Clavulanic Acids; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies | 1995 |
Cefuroxime axetil in the treatment of acute sinusitis in childhood.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Female; Humans; Male; Pharynx; Sinusitis; Staphylococcus aureus; Streptococcus; Treatment Outcome | 1996 |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 1997 |
Hospital antibiotic prescribing and feedback.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Clavulanic Acids; Drug Prescriptions; Drug Therapy, Combination; Economics, Hospital; Humans; Injections, Intravenous; Patient Compliance; Quality Assurance, Health Care; Respiratory Tract Infections; Treatment Outcome; United Kingdom | 1997 |
Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1996 |
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefdinir; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Single-Blind Method; Sinusitis; Treatment Outcome | 1997 |
Intramuscular ceftriaxone compared with oral amoxicillin-clavulanate for treatment of acute otitis media in children.
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intramuscular; Male; Otitis Media; Statistics, Nonparametric | 1997 |
[Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 1997 |
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Treatment Outcome | 1998 |
[Antibiotic prophylaxis of infectious complications in gynecologic surgery].
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bacterial Infections; Cefamandole; Cephalosporins; Drug Therapy, Combination; Female; Humans; Hysterectomy; Middle Aged; Postoperative Complications | 1997 |
[Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1998 |
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method; Treatment Outcome | 1998 |
One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child, Preschool; Drug Administration Schedule; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Nasopharynx; Otitis Media with Effusion; Prospective Studies; Streptococcus pneumoniae; Treatment Outcome | 1999 |
A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis; Ceftriaxone; Cephalosporins; Chronic Disease; Drug Administration Schedule; Drug Costs; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pneumonia | 1999 |
Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Patient Dropouts | 1999 |
Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefuroxime; Cephalosporins; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media with Effusion; Treatment Outcome | 1999 |
Preoperative antibiotic prophylaxis in orthognathic surgery: a randomized, double-blind, and placebo-controlled clinical study.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Maxilla; Needs Assessment; Osteotomy, Le Fort; Outcome Assessment, Health Care; Prospective Studies; Statistics, Nonparametric; Surgical Wound Infection | 1999 |
Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Single-Blind Method | 1999 |
Efficacy and safety of cefdinir in the treatment of maxillary sinusitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Treatment Outcome | 2000 |
[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].
Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies | 2000 |
Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media, Suppurative; Treatment Outcome | 2000 |
Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media, Suppurative; Treatment Outcome | 2000 |
Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Single-Blind Method; Smell; Suspensions; Taste | 2000 |
Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method | 2001 |
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Penicillins; Pneumonia, Bacterial; Streptococcus pneumoniae | 2001 |
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefuroxime; Cephalosporins; Child, Preschool; Colony Count, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Male; Nasopharynx; Otitis Media; Prodrugs; Prospective Studies; Saliva | 2001 |
A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Researcher-Subject Relations; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Area Under Curve; Body Fluids; Cefaclor; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Ear, Middle; Female; Humans; Male | 2003 |
Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Treatment Outcome | 2004 |
Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Clinical Trials, Phase IV as Topic; Drug Tolerance; Female; Humans; Infant; Male; Otitis Media; Parents; Patient Compliance; Patient Satisfaction; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Suspensions; Treatment Outcome | 2004 |
Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin-clavulanate.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Child; Colony Count, Microbial; Haemophilus influenzae; Humans; Moraxella catarrhalis; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Time Factors | 2005 |
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Cefdinir; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Otitis Media; Parents; Prospective Studies; Treatment Outcome | 2006 |
Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Recurrence; Rhinitis; Sinusitis | 2008 |
Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Doxycycline; Drug Administration Schedule; Female; Housing, Animal; Male; Respiratory Tract Infections | 2012 |
Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Drug Administration Schedule; Follow-Up Studies; Humans; Infant; Otitis Media; Prospective Studies; Single-Blind Method; Treatment Outcome | 2012 |
Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Tigecycline | 2015 |
108 other study(ies) available for cephalosporin c and amoxicillin-potassium clavulanate combination
Article | Year |
---|---|
Bactericidal activity and postantibiotic effect of cefdinir (Cl 983, FK 482) against selected pathogens.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefdinir; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Kinetics; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporin.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ceftriaxone; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Stability; Imipenem | 1991 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benzothiazoles; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Stability; Methicillin; Species Specificity; Staphylococcus aureus; Staphylococcus epidermidis | 1990 |
[Sensitivity of Salmonella strains to Augmentin and new generation cephalosporins and aminoglycosides].
Topics: Adult; Aminoglycosides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 1989 |
[How I do it. Perioperative preventive use of antibiotics in tumor surgery of the head and neck].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Premedication; Surgical Wound Infection | 1989 |
Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Humans; Moraxella catarrhalis; Respiratory Tract Infections | 1988 |
Salt-supplemented medium for testing methicillin-resistant staphylococci with newer beta-lactams.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Sodium Chloride; Staphylococcus; Staphylococcus aureus; Ticarcillin | 1988 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefaclor; Ceftizoxime; Cephalosporins; Clavulanic Acids; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1985 |
Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Topics: Agar; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Cefotaxime; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1995 |
Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Italy; Serotyping | 1994 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
The pharmacokinetics, tissue penetration and in-vitro activity of loracarbef, a beta-lactam antibiotic of the carbacephem class.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Exudates and Transudates; Haemophilus influenzae; Half-Life; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae | 1993 |
Partial characterization of Nocardia farcinica beta-lactamases.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Penicillins; Substrate Specificity | 1993 |
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Haemophilus influenzae; Microbial Sensitivity Tests | 1993 |
Analysis of beta-lactamases produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cephalosporins; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Ticarcillin | 1995 |
First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cephalothin; Clavulanic Acids; DNA, Bacterial; Drug Resistance, Microbial; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Escherichia coli; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 1995 |
Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefotaxime; Cephalosporins; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1996 |
Therapy for acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxone; Cephalosporins; Child; Clavulanic Acids; Drug Therapy, Combination; Humans; Otitis Media; Parents; Treatment Failure | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
beta-Lactamase producing bacteria in adult periodontitis.
Topics: Actinomyces; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Bacteroides; beta-Lactamases; Campylobacter; Cephalosporins; Chromogenic Compounds; Clavulanic Acids; Culture Media; Dental Plaque; Fusobacterium nucleatum; Gingiva; Humans; Indicators and Reagents; Penicillins; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella; Prevotella intermedia | 1997 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Humans; Pneumonia, Bacterial | 1997 |
Antibiotics utilization during the war period: influence of drug donations.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anesthesia Department, Hospital; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalexin; Cephalosporins; Critical Care; Croatia; Drug Therapy, Combination; Drug Utilization; Gentamicins; Hospital Bed Capacity, 500 and over; Hospital Records; Hospitals, University; Humans; International Cooperation; Metronidazole; Penicillins; Pharmacy Service, Hospital; Quality of Health Care; Relief Work; Surgery Department, Hospital; Trimethoprim, Sulfamethoxazole Drug Combination; Warfare | 1997 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Bone Conduction; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Glucocorticoids; Hearing Loss; Hearing Loss, Conductive; Humans; Male; Middle Aged; Otitis Media; Penicillins; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1998 |
Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiosis; Cefprozil; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Infant; Male; Nasopharynx; Otitis Media | 1998 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
Transnasal endoscopic drainage of a medial subperiosteal orbital abscess.
Topics: Abscess; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drainage; Drug Therapy, Combination; Endoscopy; Ethmoid Bone; Ethmoid Sinusitis; Female; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Nose; Orbital Diseases; Periosteum; Sinusitis; Tomography, X-Ray Computed; Treatment Failure | 1998 |
Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Child; Drug Hypersensitivity; Female; Humans; Immunocompromised Host; Kidney Transplantation; Listeria monocytogenes; Meningitis, Listeria; Meropenem; Thienamycins | 1998 |
The benefits of antibiotic prophylaxis for groin repair.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Drug Therapy, Combination; Hernia, Inguinal; Humans; Surgical Wound Infection | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalosporins; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Outpatients; Penicillin G; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Roxithromycin; Streptococcus pneumoniae | 1998 |
[Management of community-acquired pneumopathies of adults in the city and at the hospital].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Hospitalization; Humans; Penicillin G; Penicillin Resistance; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Radiography, Thoracic | 1998 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
Cefpodoxime: new dosage. A new, unproven, dose regimen.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ceftizoxime; Cephalosporins; Drug Therapy, Combination; Humans; Penicillin V; Penicillins; Pharyngitis; Recurrence; Treatment Outcome | 1998 |
Prophylactic antibiotics in recurrent parotitis in a patient with Sjogren's syndrome.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Cephalexin; Cephalosporins; Drug Therapy, Combination; Female; Humans; Parotid Diseases; Parotid Gland; Secondary Prevention; Sjogren's Syndrome; Treatment Outcome | 1999 |
Antimicrobial treatment of an experimental otitis media caused by a beta-lactamase positive isolate of Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; beta-Lactamases; Cefuroxime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Otitis Media with Effusion; Treatment Outcome | 1999 |
Prescribing antimicrobial agents for treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Otitis Media; Practice Patterns, Physicians'; Streptococcus pneumoniae | 1999 |
Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 1999 |
Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefuroxime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Gerbillinae; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Otitis Media; Otitis Media with Effusion; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
Palatability of oral antibiotics among children in an urban primary care center.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Cefixime; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Flavoring Agents; Humans; Male; Pain Measurement; Patient Acceptance of Health Care; Taste; Urban Population | 2000 |
Imipenem therapy for septicemic melioidosis in a child with penicillin and cephalosporin adverse reaction.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Diabetes Complications; Drug Therapy, Combination; Humans; Imipenem; Male; Melioidosis; Thienamycins | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Penicillins; Practice Guidelines as Topic; Prospective Studies | 2000 |
Recurrent temporal petrositis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Humans; Male; Middle Ear Ventilation; Ocular Motility Disorders; Otitis Media, Suppurative; Petrous Bone; Recurrence; Tomography, X-Ray Computed | 2001 |
Prevalence of resistance to antimicrobials of Escherichia coli isolates from clinical sources at a private hospital in Trinidad.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Gentamicins; Hospitals, Private; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Tetracycline; Trinidad and Tobago | 2001 |
Antibiotic prophylaxis in elective colorectal surgery.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Cephalosporins; Colorectal Surgery; Cross-Sectional Studies; Elective Surgical Procedures; Evidence-Based Medicine; Humans; Metronidazole; Surgical Wound Infection; Surveys and Questionnaires | 2002 |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
Topics: Amino Acid Sequence; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Genes, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial | 2002 |
First occurrence of transferable extended-spectrum beta-lactamase hydrolyzing cefoperazone in multiresistant nosocomial strains of Klebsiella pneumoniae from two hospitals in Czech and Slovak Republics.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefoperazone; Cephalosporins; Cross Infection; Czech Republic; Drug Interactions; Drug Resistance, Multiple; Escherichia coli; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Proteus mirabilis; Slovakia | 2002 |
In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Culture Media; Drug Therapy, Combination; Erythromycin; Humans; Ketolides; Kinetics; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
[Urinary microflora in children from different pediatric departments].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; Inpatients; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Staphylococcus aureus; Urine | 2003 |
Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria).
Topics: Acute Disease; Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cephalosporins; Child; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization Review; Europe; Europe, Eastern; Humans; International Classification of Diseases; Macrolides; Otitis Media; Practice Patterns, Physicians' | 2004 |
Estimation of the intervention effect in a non-randomized study with pre- and post-mismeasured binary responses.
Topics: Acoustic Impedance Tests; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bias; Cefdinir; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Computer Simulation; Diagnostic Errors; Humans; Infant; Otitis Media with Effusion; Treatment Outcome | 2005 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blister; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1989 |
Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteriological Techniques; Cephalosporins; Child; Chronic Disease; Female; Haemophilus Infections; Humans; Macrolides; Male; Maxillary Sinus; Maxillary Sinusitis; Microbial Sensitivity Tests; Nasal Mucosa; Nasal Polyps; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Statistics as Topic; Treatment Outcome | 2006 |
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Azithromycin; beta-Lactamases; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Ketolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Quinolines; Selection, Genetic | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2006 |
[Comments on the XV(e) consensus conference: "Managing low tract respiratory infections in the immunocompetent adult"].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Consensus Development Conferences as Topic; Disease Management; Drug Therapy, Combination; Humans; Immunocompetence; Pneumonia; Practice Guidelines as Topic; Quinolones | 2007 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cefazolin; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Ofloxacin; Prospective Studies; Sinusitis; Sulbactam | 2007 |
Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefuroxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Half-Life; Kinetics; Microbial Sensitivity Tests; Phenotype | 2007 |
Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT).
Topics: Administration, Oral; Algorithms; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Data Collection; Drug Therapy, Combination; Drug Utilization; Glycopeptides; Hospitals; Humans; Injections, Intravenous; Metronidazole; Prevalence; Scotland | 2007 |
Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2007 |
influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhi
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Genes, Bacterial; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests; Peptidoglycan Glycosyltransferase; Protein Binding; Spectrophotometry, Ultraviolet | 2007 |
A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Length of Stay; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2008 |
[Managing children skin and soft tissue infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Should we change antibiotic prophylaxis for lung surgery? Postoperative pneumonia is the critical issue.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bronchitis; Case-Control Studies; Cefamandole; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Education, Medical, Continuing; Female; Follow-Up Studies; France; Humans; Incidence; Lung Diseases; Male; Middle Aged; Multivariate Analysis; Pneumonectomy; Pneumonia, Bacterial; Postoperative Complications; Preoperative Care; Probability; Prospective Studies; Reference Values; Risk Assessment; Surgical Wound Infection; Survival Rate | 2008 |
[High mortality. Elderly pneumonia patients need aggressive therapy].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Fluoroquinolones; Humans; Pneumonia, Bacterial; Risk Factors | 2008 |
Association between antimicrobial consumption and resistance in Escherichia coli.
Topics: Ambulatory Care Facilities; Amdinocillin Pivoxil; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Infective Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Finland; Fluoroquinolones; Hospitals, Community; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Prospective Studies; Switzerland; Urinary Tract Infections; Urine | 2008 |
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections | 2009 |
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefuroxime; Cephalosporins; Coculture Techniques; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Selection, Genetic | 2009 |
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Drug Utilization; Humans; Infant; Macrolides; Otitis Media; United States | 2009 |
In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Ceftaroline; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2010 |
Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma.
Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan | 2009 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
Improving turnaround time for identifying extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: experience with the BD Phoenix automated system.
Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Automation, Laboratory; Bacteriological Techniques; beta-Lactamases; Cephalosporins; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Time Factors | 2011 |
Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Diffusion; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2011 |
Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Rifampin; Wound Infection | 2011 |
[Resistance to B-lactamines of bacteria responsible for endodontic root canal infections].
Topics: Actinomyces; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteriological Techniques; Bacteroides; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Cephalosporins; Dental Pulp Cavity; Dental Pulp Necrosis; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Indicators and Reagents; Peptostreptococcus; Periapical Periodontitis; Prevotella; Streptococcus | 2010 |
Genetic characterization of the mechanisms of resistance to amoxicillin/clavulanate and third-generation cephalosporins in Salmonella enterica from three Spanish hospitals.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Spain | 2011 |
[Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Urinary Tract Infections | 2012 |
[Bacterial pneumonia in HIV-infected patients (excluding mycobacterial infection)].
Topics: Actinomycetales Infections; AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cephalosporins; Community-Acquired Infections; Evidence-Based Medicine; France; Haemophilus influenzae; HIV Infections; Humans; Immunocompromised Host; Influenza Vaccines; Nocardia Infections; Pneumococcal Vaccines; Pneumonia, Bacterial; Rhodococcus equi; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2012 |
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefuroxime; Cephalexin; Cephalosporins; Child; Child, Preschool; Clindamycin; Cochlear Implantation; Cochlear Implants; Drainage; Female; Hearing Loss, Sensorineural; Humans; Infant; Infusions, Intravenous; Male; Mastoiditis; Otitis Media; Prosthesis-Related Infections; Retrospective Studies; Risk Factors | 2013 |
Beta-lactamic resistance profiles in Porphyromonas, Prevotella, and Parvimonas species isolated from acute endodontic infections.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Dental Pulp Diseases; Gram-Positive Bacterial Infections; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Phenotype; Porphyromonas; Porphyromonas endodontalis; Porphyromonas gingivalis; Prevotella; Prevotella intermedia; Prevotella nigrescens | 2014 |
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests | 2014 |
Alopecic and Aseptic Nodules of the Scalp/Pseudocyst of the Scalp: Clinicopathological and Therapeutic Analyses in 11 Korean Patients.
Topics: Adolescent; Adult; Alopecia; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cephalosporins; Child; Drug Therapy, Combination; Epidermal Cyst; Humans; Injections, Intralesional; Male; Republic of Korea; Retrospective Studies; Scalp Dermatoses; Triamcinolone; Young Adult | 2016 |
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide surveillance system.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter; Escherichia coli; Female; Hospitalization; Humans; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Respiratory System; Retrospective Studies; Staphylococcus aureus; Streptococcus pneumoniae | 2018 |
Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Female; Humans; Macrolides; Male; Otitis Media; Pharyngitis; Primary Health Care; Quality of Life; Respiratory Tract Infections; Retrospective Studies; Sinusitis; Streptococcal Infections; Streptococcus pyogenes; Treatment Failure | 2017 |
Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Pneumonia, Bacterial; Retrospective Studies | 2018 |
Re: 'Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?' by Batard, et al.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Humans; Pneumonia; Prognosis | 2018 |
Are third-generation cephalosporins associated with a better prognosis than amoxicillin/clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?-Author's reply.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Humans; Pneumonia; Prognosis | 2018 |
Significance of the detection of influenza and other respiratory viruses for antibiotic stewardship: Lessons from the post-pandemic period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; C-Reactive Protein; Cephalosporins; Child; Child, Preschool; Female; Fluoroquinolones; Humans; Infant; Influenza, Human; Macrolides; Male; Middle Aged; Pandemics; Respiratory Tract Infections; Retrospective Studies; Turkey; Virus Diseases; Young Adult | 2018 |
Urinary Tract Infection in Children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cystitis; Drug Resistance, Bacterial; Dysuria; Escherichia coli; Escherichia coli Infections; Fever; Humans; Infant; Pyelonephritis; Urinary Tract Infections | 2019 |
Clinical efficacy of amoxicillin/clavulanate plus cefditoren as de-escalation combination therapy for endocarditis due to strongly biofilm-forming
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Humans; Length of Stay; Male; Middle Aged; Treatment Outcome | 2020 |
Antibiotypes and high frequency of toxin genes in methicillin-resistant Staphylococcus pseudintermedius from nares of dogs and dog guardians in Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Dog Diseases; Dogs; Fluoroquinolones; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nigeria; Staphylococcal Infections; Staphylococcus | 2022 |
Antimicrobials in dog-to-dog bite wounds: A retrospective study of 1526 dog bite events (1999-2019).
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Australia; Cephalosporins; Dogs; Retrospective Studies | 2022 |
Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Humans; Inpatients; Neoplasms; Retrospective Studies | 2023 |
Antibiotic associated diarrhea in outpatient pediatric antibiotic therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Diarrhea; Humans; Outpatients; Prospective Studies | 2023 |
Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Humans; Mammals | 2023 |